{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:45:46Z","timestamp":1790819146425,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T00:00:00Z","timestamp":1502928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T00:00:00Z","timestamp":1502928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Modified Vaccinia virus Ankara (MVA) is a promising vaccine vector with an excellent safety profile. However, despite extensive pre-clinical and clinical testing, surprisingly little is known about the cellular tropism of MVA, especially in relevant animal species. Here, we performed\n                    <jats:italic>in vitro<\/jats:italic>\n                    ,\n                    <jats:italic>ex vivo<\/jats:italic>\n                    and\n                    <jats:italic>in vivo<\/jats:italic>\n                    experiments with recombinant MVA expressing green fluorescent protein (rMVA-GFP). In both human peripheral blood mononuclear cells and mouse lung explants, rMVA-GFP predominantly infected antigen presenting cells. Subsequent\n                    <jats:italic>in vivo<\/jats:italic>\n                    experiments performed in mice, ferrets and non-human primates indicated that preferential targeting of dendritic cells and alveolar macrophages was observed after respiratory administration, although subtle differences were observed between the respective animal species. Following intramuscular injection, rMVA-GFP was detected in interdigitating cells between myocytes, but also in myocytes themselves. These data are important in advancing our understanding of the basis for the immunogenicity of MVA-based vaccines and aid rational vaccine design and delivery strategies.\n                  <\/jats:p>","DOI":"10.1038\/s41598-017-08719-y","type":"journal-article","created":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T07:41:18Z","timestamp":1502437278000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In Vivo"],"prefix":"10.1038","volume":"7","author":[{"given":"Arwen F.","family":"Altenburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolien E.","family":"van de Sandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobby W. S.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan J.","family":"MacLoughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron A. M.","family":"Fouchier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"van Amerongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asisa","family":"Volz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudi W.","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik L.","family":"de Swart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guus F.","family":"Rimmelzwaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory D.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,17]]},"reference":[{"issue":"Pt 5","key":"8719_CR1","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1099\/0022-1317-72-5-1031","volume":"72","author":"H Meyer","year":"1991","unstructured":"Meyer, H., Sutter, G. & Mayr, A. Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence. J. Gen. Virol. 72(Pt 5), 1031\u20131038, doi:10.1099\/0022-1317-72-5-1031 (1991).","journal-title":"J. Gen. Virol."},{"key":"8719_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0091-7435(74)90066-8","volume":"3","author":"HA Stickl","year":"1974","unstructured":"Stickl, H. A. Smallpox vaccination and its consequences: first experiences with the highly attenuated smallpox vaccine \u201cMVA\u201d. Prev Med 3, 97\u2013101 (1974).","journal-title":"Prev Med"},{"key":"8719_CR3","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1016\/j.vaccine.2012.02.016","volume":"30","author":"C Verheust","year":"2012","unstructured":"Verheust, C., Goossens, M., Pauwels, K. & Breyer, D. Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination. Vaccine 30, 2623\u20132632, doi:10.1016\/j.vaccine.2012.02.016 (2012).","journal-title":"Vaccine"},{"key":"8719_CR4","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1016\/S0264-410X(01)00075-5","volume":"19","author":"KJ Stittelaar","year":"2001","unstructured":"Stittelaar, K. J. et al. Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques. Vaccine 19, 3700\u20133709 (2001).","journal-title":"Vaccine"},{"key":"8719_CR5","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.3390\/v6072735","volume":"6","author":"AF Altenburg","year":"2014","unstructured":"Altenburg, A. F. et al. Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases. Viruses 6, 2735\u20132761, doi:10.3390\/v6072735 (2014).","journal-title":"Viruses"},{"key":"8719_CR6","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1080\/21645515.2016.1210729","volume":"12","author":"RD de Vries","year":"2016","unstructured":"de Vries, R. D. & Rimmelzwaan, G. F. Viral vector-based influenza vaccines. Hum Vaccin Immunother 12, 2881\u20132901, doi:10.1080\/21645515.2016.1210729 (2016).","journal-title":"Hum Vaccin Immunother"},{"key":"8719_CR7","doi-asserted-by":"publisher","unstructured":"Ramezanpour, B., Haan, I., Osterhaus, A. & Claassen, E. Vector-based genetically modified vaccines: Exploiting Jenner\u2019s legacy. Vaccine, doi:10.1016\/j.vaccine.2016.06.059 (2016).","DOI":"10.1016\/j.vaccine.2016.06.059"},{"key":"8719_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.virol.2005.09.037","volume":"344","author":"B Moss","year":"2006","unstructured":"Moss, B. Poxvirus entry and membrane fusion. Virology 344, 48\u201354, doi:10.1016\/j.virol.2005.09.037 (2006).","journal-title":"Virology"},{"key":"8719_CR9","doi-asserted-by":"publisher","first-page":"10397","DOI":"10.1128\/JVI.79.16.10397-10407.2005","volume":"79","author":"A Chahroudi","year":"2005","unstructured":"Chahroudi, A. et al. Vaccinia virus tropism for primary hematolymphoid cells is determined by restricted expression of a unique virus receptor. Journal of virology 79, 10397\u201310407, doi:10.1128\/JVI.79.16.10397-10407.2005 (2005).","journal-title":"Journal of virology"},{"key":"8719_CR10","doi-asserted-by":"crossref","first-page":"8750","DOI":"10.1128\/JVI.73.10.8750-8761.1999","volume":"73","author":"JC Hsiao","year":"1999","unstructured":"Hsiao, J. C., Chung, C. S. & Chang, W. Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells. Journal of virology 73, 8750\u20138761 (1999).","journal-title":"Journal of virology"},{"key":"8719_CR11","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1128\/JVI.74.7.3353-3365.2000","volume":"74","author":"CL Lin","year":"2000","unstructured":"Lin, C. L., Chung, C. S., Heine, H. G. & Chang, W. Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo. Journal of virology 74, 3353\u20133365 (2000).","journal-title":"Journal of virology"},{"key":"8719_CR12","doi-asserted-by":"publisher","first-page":"14216","DOI":"10.1073\/pnas.0403597101","volume":"101","author":"V von Messling","year":"2004","unstructured":"von Messling, V., Milosevic, D. & Cattaneo, R. Tropism illuminated: lymphocyte-based pathways blazed by lethal morbillivirus through the host immune system. Proceedings of the National Academy of Sciences of the United States of America 101, 14216\u201314221, doi:10.1073\/pnas.0403597101 (2004).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"8719_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0030178","volume":"3","author":"RL de Swart","year":"2007","unstructured":"de Swart, R. L. et al. Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog 3, e178, doi:10.1371\/journal.ppat.0030178 (2007).","journal-title":"PLoS Pathog"},{"key":"8719_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1145","volume":"1","author":"O Kobiler","year":"2010","unstructured":"Kobiler, O., Lipman, Y., Therkelsen, K., Daubechies, I. & Enquist, L. W. Herpesviruses carrying a Brainbow cassette reveal replication and expression of limited numbers of incoming genomes. Nat Commun 1, 146, doi:10.1038\/ncomms1145 (2010).","journal-title":"Nat Commun"},{"key":"8719_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7600","volume":"6","author":"S Fukuyama","year":"2015","unstructured":"Fukuyama, S. et al. Multi-spectral fluorescent reporter influenza viruses (Color-flu) as powerful tools for in vivo studies. Nat Commun 6, 6600, doi:10.1038\/ncomms7600 (2015).","journal-title":"Nat Commun"},{"key":"8719_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0022-1759(98)00156-2","volume":"220","author":"J Dominguez","year":"1998","unstructured":"Dominguez, J., Lorenzo, M. M. & Blasco, R. Green fluorescent protein expressed by a recombinant vaccinia virus permits early detection of infected cells by flow cytometry. Journal of immunological methods 220, 115\u2013121 (1998).","journal-title":"Journal of immunological methods"},{"key":"8719_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-1-10","volume":"1","author":"JM Sanchez-Puig","year":"2004","unstructured":"Sanchez-Puig, J. M., Sanchez, L., Roy, G. & Blasco, R. Susceptibility of different leukocyte cell types to Vaccinia virus infection. Virology journal 1, 10, doi:10.1186\/1743-422X-1-10 (2004).","journal-title":"Virology journal"},{"key":"8719_CR18","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3109\/14653249.2010.549123","volume":"13","author":"C Flechsig","year":"2011","unstructured":"Flechsig, C. et al. Uptake of antigens from modified vaccinia Ankara virus-infected leukocytes enhances the immunostimulatory capacity of dendritic cells. Cytotherapy 13, 739\u2013752, doi:10.3109\/14653249.2010.549123 (2011).","journal-title":"Cytotherapy"},{"key":"8719_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2172-9-15","volume":"9","author":"L Liu","year":"2008","unstructured":"Liu, L., Chavan, R. & Feinberg, M. B. Dendritic cells are preferentially targeted among hematolymphocytes by Modified Vaccinia Virus Ankara and play a key role in the induction of virus-specific T cell responses in vivo. BMC immunology 9, 15, doi:10.1186\/1471-2172-9-15 (2008).","journal-title":"BMC immunology"},{"key":"8719_CR20","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1128\/JVI.01884-08","volume":"83","author":"MH Lehmann","year":"2009","unstructured":"Lehmann, M. H. et al. Modified vaccinia virus ankara triggers chemotaxis of monocytes and early respiratory immigration of leukocytes by induction of CCL2 expression. J. Virol. 83, 2540\u20132552, doi:10.1128\/JVI.01884-08 (2009).","journal-title":"J. Virol."},{"key":"8719_CR21","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00705-003-0006-z","volume":"148","author":"JC Ramirez","year":"2003","unstructured":"Ramirez, J. C., Finke, D., Esteban, M., Kraehenbuhl, J. P. & Acha-Orbea, H. Tissue distribution of the Ankara strain of vaccinia virus (MVA) after mucosal or systemic administration. Archives of virology 148, 827\u2013839, doi:10.1007\/s00705-003-0006-z (2003).","journal-title":"Archives of virology"},{"issue":"2","key":"8719_CR22","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1128\/JVI.74.2.923-933.2000","volume":"74","author":"JC Ramirez","year":"2000","unstructured":"Ramirez, J. C., Gherardi, M. M. & Esteban, M. Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine. Journal of virology 74(2), 923\u2013933 (2000).","journal-title":"Journal of virology"},{"key":"8719_CR23","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1165\/rcmb.2013-0086MA","volume":"49","author":"AV Misharin","year":"2013","unstructured":"Misharin, A. V., Morales-Nebreda, L., Mutlu, G. M., Budinger, G. R. & Perlman, H. Flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung. Am. J. Respir. Cell Mol. Biol. 49, 503\u2013510, doi:10.1165\/rcmb.2013-0086MA (2013).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"8719_CR24","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1073\/pnas.0705191105","volume":"105","author":"M Corbett","year":"2008","unstructured":"Corbett, M. et al. Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic. Proceedings of the National Academy of Sciences of the United States of America 105, 2046\u20132051, doi:10.1073\/pnas.0705191105 (2008).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"8719_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001263","volume":"7","author":"K Lemon","year":"2011","unstructured":"Lemon, K. et al. Early target cells of measles virus after aerosol infection of non-human primates. PLoS Pathog 7, e1001263, doi:10.1371\/journal.ppat.1001263 (2011).","journal-title":"PLoS Pathog"},{"key":"8719_CR26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1089\/jamp.2015.1250","volume":"29","author":"RJ MacLoughlin","year":"2016","unstructured":"MacLoughlin, R. J. et al. Optimization and Dose Estimation of Aerosol Delivery to Non-Human Primates. J Aerosol Med Pulm Drug Deliv 29, 281\u2013287, doi:10.1089\/jamp.2015.1250 (2016).","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"8719_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c7297","volume":"342","author":"DM Skowronski","year":"2011","unstructured":"Skowronski, D. M. et al. Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. BMJ 342, c7297, doi:10.1136\/bmj.c7297 (2011).","journal-title":"BMJ"},{"key":"8719_CR28","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1164\/rccm.200912-1878CP","volume":"181","author":"T Kotsimbos","year":"2010","unstructured":"Kotsimbos, T. et al. Influenza A\/H1N1_09: Australia and New Zealand\u2019s winter of discontent. Am J Respir Crit Care Med 181, 300\u2013306, doi:10.1164\/rccm.200912-1878CP (2010).","journal-title":"Am J Respir Crit Care Med"},{"key":"8719_CR29","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.vaccine.2012.11.047","volume":"31","author":"AC Boyd","year":"2013","unstructured":"Boyd, A. C. et al. Towards a universal vaccine for avian influenza: protective efficacy of modified Vaccinia virus Ankara and Adenovirus vaccines expressing conserved influenza antigens in chickens challenged with low pathogenic avian influenza virus. Vaccine 31, 670\u2013675, doi:10.1016\/j.vaccine.2012.11.047 (2013).","journal-title":"Vaccine"},{"key":"8719_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088340","volume":"9","author":"A Hessel","year":"2014","unstructured":"Hessel, A. et al. MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 viruses. PLoS One 9, e88340, doi:10.1371\/journal.pone.0088340 (2014).","journal-title":"PLoS One"},{"key":"8719_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/bs.aivir.2016.07.001","volume":"97","author":"A Volz","year":"2017","unstructured":"Volz, A. & Sutter, G. Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development. Adv Virus Res 97, 187\u2013243, doi:10.1016\/bs.aivir.2016.07.001 (2017).","journal-title":"Adv Virus Res"},{"key":"8719_CR32","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1001\/jama.2016.4218","volume":"315","author":"ID Milligan","year":"2016","unstructured":"Milligan, I. D. et al. Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial. JAMA 315, 1610\u20131623, doi:10.1001\/jama.2016.4218 (2016).","journal-title":"JAMA"},{"key":"8719_CR33","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1016\/j.vaccine.2004.02.011","volume":"22","author":"OJ Ophorst","year":"2004","unstructured":"Ophorst, O. J. et al. An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity. Vaccine 22, 3035\u20133044, doi:10.1016\/j.vaccine.2004.02.011 (2004).","journal-title":"Vaccine"},{"key":"8719_CR34","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/jmv.21667","volume":"82","author":"H Liu","year":"2010","unstructured":"Liu, H. et al. The route of inoculation determines the tissue tropism of modified vaccinia Tiantan expressing the spike glycoprotein of SARS-CoV in mice. J Med Virol 82, 727\u2013734, doi:10.1002\/jmv.21667 (2010).","journal-title":"J Med Virol"},{"key":"8719_CR35","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1084\/jem.20091472","volume":"206","author":"S Halle","year":"2009","unstructured":"Halle, S. et al. Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells. J. Exp. Med. 206, 2593\u20132601, doi:10.1084\/jem.20091472 (2009).","journal-title":"J. Exp. Med."},{"key":"8719_CR36","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.immuni.2012.07.015","volume":"37","author":"D Duffy","year":"2012","unstructured":"Duffy, D. et al. Neutrophils transport antigen from the dermis to the bone marrow, initiating a source of memory CD8+ T cells. Immunity 37, 917\u2013929, doi:10.1016\/j.immuni.2012.07.015 (2012).","journal-title":"Immunity"},{"key":"8719_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1089\/jamp.2011.0931","volume":"25","author":"WF Tonnis","year":"2012","unstructured":"Tonnis, W. F. et al. Pulmonary vaccine delivery: a realistic approach? J Aerosol Med Pulm Drug Deliv 25, 249\u2013260, doi:10.1089\/jamp.2011.0931 (2012).","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"8719_CR38","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/infdis\/jis641","volume":"207","author":"MI Barria","year":"2013","unstructured":"Barria, M. I. et al. Localized mucosal response to intranasal live attenuated influenza vaccine in adults. J Infect Dis 207, 115\u2013124, doi:10.1093\/infdis\/jis641 (2013).","journal-title":"J Infect Dis"},{"key":"8719_CR39","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1473-3099(14)70845-X","volume":"14","author":"I Satti","year":"2014","unstructured":"Satti, I. et al. Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial. Lancet Infect Dis 14, 939\u2013946, doi:10.1016\/S1473-3099(14)70845-X (2014).","journal-title":"Lancet Infect Dis"},{"key":"8719_CR40","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1086\/315323","volume":"181","author":"RB Belshe","year":"2000","unstructured":"Belshe, R. B. et al. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis 181, 1133\u20131137, doi:10.1086\/315323 (2000).","journal-title":"J Infect Dis"},{"key":"8719_CR41","doi-asserted-by":"publisher","first-page":"6794","DOI":"10.1016\/j.vaccine.2012.09.018","volume":"30","author":"CS Ambrose","year":"2012","unstructured":"Ambrose, C. S., Wu, X., Jones, T. & Mallory, R. M. The role of nasal IgA in children vaccinated with live attenuated influenza vaccine. Vaccine 30, 6794\u20136801, doi:10.1016\/j.vaccine.2012.09.018 (2012).","journal-title":"Vaccine"},{"key":"8719_CR42","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1128\/CVI.00690-12","volume":"20","author":"AD White","year":"2013","unstructured":"White, A. D. et al. Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques. Clinical and vaccine immunology: CVI 20, 663\u2013672, doi:10.1128\/CVI.00690-12 (2013).","journal-title":"Clinical and vaccine immunology: CVI"},{"key":"8719_CR43","doi-asserted-by":"crossref","first-page":"497","DOI":"10.4049\/jimmunol.136.2.497","volume":"136","author":"MF Lipscomb","year":"1986","unstructured":"Lipscomb, M. F. et al. Human alveolar macrophages: HLA-DR-positive macrophages that are poor stimulators of a primary mixed leukocyte reaction. J Immunol 136, 497\u2013504 (1986).","journal-title":"J Immunol"},{"key":"8719_CR44","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1164\/arrd.1986.133.6.1091","volume":"133","author":"DB Ettensohn","year":"1986","unstructured":"Ettensohn, D. B., Lalor, P. A. & Roberts, N. J. Jr. Human alveolar macrophage regulation of lymphocyte proliferation. Am Rev Respir Dis 133, 1091\u20131096, doi:10.1164\/arrd.1986.133.6.1091 (1986).","journal-title":"Am Rev Respir Dis"},{"key":"8719_CR45","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.4049\/jimmunol.137.4.1173","volume":"137","author":"CR Lyons","year":"1986","unstructured":"Lyons, C. R. et al. Inability of human alveolar macrophages to stimulate resting T cells correlates with decreased antigen-specific T cell-macrophage binding. J Immunol 137, 1173\u20131180 (1986).","journal-title":"J Immunol"},{"key":"8719_CR46","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1084\/jem.167.2.262","volume":"167","author":"PG Holt","year":"1988","unstructured":"Holt, P. G., Schon-Hegrad, M. A. & Oliver, J. MHC class II antigen-bearing dendritic cells in pulmonary tissues of the rat. Regulation of antigen presentation activity by endogenous macrophage populations. The Journal of experimental medicine 167, 262\u2013274 (1988).","journal-title":"The Journal of experimental medicine"},{"key":"8719_CR47","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nri3166","volume":"12","author":"TJ Braciale","year":"2012","unstructured":"Braciale, T. J., Sun, J. & Kim, T. S. Regulating the adaptive immune response to respiratory virus infection. Nat Rev Immunol 12, 295\u2013305, doi:10.1038\/nri3166 (2012).","journal-title":"Nat Rev Immunol"},{"key":"8719_CR48","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1128\/JVI.03244-14","volume":"89","author":"F Thiele","year":"2015","unstructured":"Thiele, F. et al. Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways. Journal of virology 89, 2698\u20132709, doi:10.1128\/JVI.03244-14 (2015).","journal-title":"Journal of virology"},{"key":"8719_CR49","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-1-61779-876-4_4","volume":"890","author":"MVA Kremer","year":"2012","unstructured":"Kremer, M. V. A., Kreijtz, J. H. C. M., Fux, R., Lehmann, M. H. & Sutter, G. Chapter 4: Easy and Ef fi cient Protocols for Working with Recombinant Vaccinia Virus MVA. Methods Mol. Biol. 890, 59\u201392 (2012).","journal-title":"Methods Mol. Biol."},{"key":"8719_CR50","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jviromet.2013.06.016","volume":"193","author":"DT Nguyen","year":"2013","unstructured":"Nguyen, D. T. et al. Paramyxovirus infections in ex vivo lung slice cultures of different host species. J. Virol. Methods 193, 159\u2013165, doi:10.1016\/j.jviromet.2013.06.016 (2013).","journal-title":"J. Virol. Methods"},{"key":"8719_CR51","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1128\/JVI.02633-09","volume":"84","author":"RD de Vries","year":"2010","unstructured":"de Vries, R. D. et al. In vivo tropism of attenuated and pathogenic measles virus expressing green fluorescent protein in macaques. Journal of virology 84, 4714\u20134724, doi:10.1128\/JVI.02633-09 (2010).","journal-title":"Journal of virology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08719-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08719-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08719-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T19:45:29Z","timestamp":1692906329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08719-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,17]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["8719"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-08719-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,17]]},"assertion":[{"value":"8 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8580"}}